by TractManager | Mar 31, 2020 | News
The Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for hydroxychloroquine sulfate and chloroquine phosphate for the treatment of COVID-19. Based upon limited in vitro and anecdotal clinical data in case series, chloroquine phosphate...
by TractManager | Mar 30, 2020 | Health Technology Assessment
Focus of the Report: Use of Scrambler therapy (ST), also referred to as Calmare Pain Therapy and transcutaneous electrical modulation pain reprocessing (Calmare Therapeutics Inc.), for the management of chronic pain related to cancer or cancer treatment.Technology...
by TractManager | Mar 30, 2020 | News
On March 29, 2020, the Food and Drug Administration (FDA) issued guidance on sterilizers, disinfectant devices, and air purifiers during the COVID-19 public health emergency. The FDA issued this guidance to provide a policy to help expand the availability and...
by TractManager | Mar 27, 2020 | Health Technology Assessment
Focus of the Report: The focus of the report is on the use of ovarian or internal iliac vein embolization for the treatment of pelvic congestion syndrome (PCS).Technology Description: Embolization is intended to block the blood supply to the enlarged or swollen veins...
by TractManager | Mar 26, 2020 | Clinical Utility Evaluation
This report evaluates the clinical utility of liquid biopsy tests for colorectal cancer (CRC) screening to reduce CRC morbidity and mortality.If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments